Raging Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Raging Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-263,307	Closed	-$37.8M	–	50
2015 Q2	$37.8M	Buy	263,307 +38,909	+17%	+$5.55M	4.87%	5
2015 Q1	$31.6M	Sell	224,398 -91,460	-29%	-$14.1M	4.25%	9
2014 Q4	$46.8M	Buy	315,858 +139,154	+79%	+$20.4M	4.91%	6
2014 Q3	$27.2M	Sell	176,704 -76,532	-30%	-$11.5M	3.04%	12
2014 Q2	$35.5M	Sell	253,236 -6,378	-2%	-$708K	3.78%	9
2014 Q1	$28.8M	Buy	259,614 +69,463	+37%	+$7.56M	5.08%	5
2013 Q4	$18.8M	Sell	190,151 -15,258	-7%	-$1.32M	3.45%	8
2013 Q3	$15.6M	Sell	205,409 -226,525	-52%	-$14.7M	2.69%	10
2013 Q2	$24.1M	Buy	+431,934	New	+$25.5M	6.41%	3

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

MCP

Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Raging Capital Management's TARO Position: Q3 2015 in Review

Raging Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2015, closing a stake of 263,307 shares — an estimated $37.8M sold.

Raging Capital Management first reported a position in TARO in Q2 2013 and held it in 9 quarters. The position peaked at $46.8M in Q4 2014. 121 funds tracked by Wall St. Rank hold TARO as of Q3 2015.

Raging Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2015 after selling out during the quarter.
Raging Capital Management sold 263,307 Taro Pharmaceutical Industries Ltd. shares in Q3 2015, an estimated $37.8M.
Raging Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 9 quarters.
Raging Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $46.8M in Q4 2014.
121 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2015.

Based on Raging Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.